LRRK2 in Focus: A Global Browser Linking Genetic Diversity to Functional Effects
Preprint
Abstract
Background: LRRK2 variants are major contributors to Parkinsons disease (PD). Many pathogenic variants increase kinase activity, underscoring the value of functional assays in nominating therapeutic targets and kinase inhibitors as potential disease-modifying therapies. Objective: To develop an interactive resource that provides functional context and ancestry-specific variant frequencies. Methods: Genotyping and short-read sequencing data were analyzed for 101,678 individuals (61,709 PD, 39,969 controls) from the Global Parkinsons Genetics Program (GP2) and integrated with clinical and in-vitro biochemical kinase activity information. Results: The LRRK2 Browser (http://gp2.org/lrrk2browser) displays ancestry-specific genetic data for 19,596 LRRK2 variants (968 exonic, 14 disease-associated) across 11 populations, and functional data for 171 variants. Clinical annotations include age, age at onset, and family history of PD. Discussion: The publicly available LRRK2 Browser represents an open-access, multi-ancestry resource to support LRRK2 variant interpretation. It aims to enhance the translational potential of genetic and functional data for precision medicine and the implementation of gene-targeted therapies in diverse populations.Keywords
This publication has 28 references indexed in Scilit:
- Leucine-rich repeat kinase 2 (LRRK2): an update on the potential therapeutic target for Parkinson’s diseaseExpert Opinion on Therapeutic Targets, 2022
- Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2022 UpdateJournal of Parkinson’s Disease, 2022
- Identification of LRRK2 missense variants in the accelerating medicines partnership Parkinson’s disease cohortHuman Molecular Genetics, 2021
- GP2: The Global Parkinson's Genetics ProgramMovement Disorders, 2021
- Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studiesThe Lancet Neurology, 2019
- Fine-Mapping, Gene Expression and Splicing Analysis of the Disease Associated LRRK2 LocusPLOS ONE, 2013
- Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control studyThe Lancet Neurology, 2011
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's DiseaseNeuron, 2004
- Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic PathologyNeuron, 2004